Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Cancer Research|September 17, 2016
Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell-Rich TumorShin Foong Ngiow, Arabella Young, Stephen J Blake, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
OCA-B/Pou2af1 Expression in Mouse T Cells Promotes PD-1 Blockade-Induced Autoimmunity but is Dispensable for Anti-Tumor ImmunityJunhong Du, Asit K Manna, Erik P Hughes, et al.Journal of Cellular Biochemistry|June 11, 2015
The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1Abeer A Qadi, Phillippa C Taberlay, Jessica L Phillips, et al.Proceedings of the National Academy of Sciences of the United States of America|April 23, 2015
NK cells require IL-28R for optimal in vivo activityFernando Souza-Fonseca-Guimaraes, Arabella Young, Deepak Mittal, et al.Cancer Research|May 26, 2016
Adenosine 2B Receptor Expression on Cancer Cells Promotes MetastasisDeepak Mittal, Debottam Sinha, Deborah Barkauskas, et al.Proceedings of the National Academy of Sciences of the United States of America|June 21, 2017
G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesisFrancesco Casciello, Fares Al-Ejeh, Greg Kelly, et al.Cancer Discovery|September 25, 2016
Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic DiseaseJing Liu, Stephen J Blake, Michelle C R Yong, et al.Cancer Cell|September 14, 2016
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune ResponsesArabella Young, Shin Foong Ngiow, Deborah S Barkauskas, et al.Med (New York, N.Y.)|April 18, 2026
Impact of baseline medications on real-world overall survival in immune checkpoint inhibitor-treated patients with cancer in the RADIOHEAD cohortSamantha Stone, Muhammad Zaki Fadlullah, Yuxin Zhao, et al.Epigenetics|June 19, 2019
DNA methylation changes following DNA damage in prostate cancer cellsLaura P Sutton, Sarah A Jeffreys, Jessica L Phillips, et al.Pageof 5